Tektrotyd Markierungsbesteck

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

HYNIC-[D-Phe(1), Tyr(3)-octreotidi]trifluoroacetum, acidum ethylendiamini-N,N'-diaceticum

MAH:

medeo AG

ATC_code:

V09IA07

INN:

HYNIC-[D-Phe(1), Tyr(3)-octreotidi]trifluoroacetum, acidum ethylendiamini-N,N'-diaceticum

pharmaceutical_form:

Markierungsbesteck

composition:

I) Durchstechflasche 1: HYNIC-[D-Phe(1), Tyr(3)-octreotidi]trifluoroacetum 16 µg, tricinum, stannosi chloridum dihydricum, mannitolum, natrii hydroxidum aut acidum hydrochloridum, pro vitro. II) Durchstechflasche 2: acidum ethylendiamini-N,N'-diaceticum 10 mg, dinatrii phosphas dodecahydricus, natrii hydroxidum, acidum hydrochloridum aut natrii hydroxidum, pro vitro corresp. natrium 3.9 mg.

class:

A

therapeutic_group:

Radiopharmazeutika

therapeutic_area:

SPECT/CT-Rappresentazione rezeptortragender PEC e karzinoider Tumori

authorization_status:

zugelassen

authorization_date:

2018-04-25